Loading…
Based on limited metadata, this FDA Warning Letter issued to Unipharma, LLC on November 6, 2019 concerns drug products. Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided. A review of the complete warning letter would be necessary to understand the specific compliance issues cited.